DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
CancerWorld Issue #110 (December) is Live
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
25 Posts Not to Miss from ASH 2025
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
